IIRC Dr Kurtzberg insisted on not running a RCT on children. But the FDA will accept a RCT on adults. So Dr Kurtzberg can't be blamed for Ryoncil's lack of progress.
As for COVID-ARDS, it would be amazing if overwhelming efficacy (and satisfactory safety) at an interim readout wasn't sufficient to get an EUA, given that it should be sufficient to get full approval.
IIRC Dr Kurtzberg insisted on not running a RCT on children. But...
-
- There are more pages in this discussion • 339 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.080(8.42%) |
Mkt cap ! $1.176B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | $1.03 | 95.0¢ | $43.38M | 42.28M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 72752 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 205100 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |